Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains
Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains
复制标题
DOI:
10.1006/viro.1999.9855
复制
发表时间:
1999-08-15
期刊:
影响因子:
3.7
通讯作者:
Raab-Traub, N
中科院分区:
文献类型:
--
作者:
Edwards, RH;Seillier-Moiseiwitsch, F;Raab-Traub, N
Sequence variations in the Epstein-Barr virus (EBV) latent membrane protein 1 gene have been described in numerous EBV-associated tumors with some of these variations, most notably a 30-base pair deletion in the cytoplasmic carboxyl-terminal domain, suggested as associated with an increase in tumorigenicity. In this study, EBV DNA sequence was determined from 92 tissue specimens or cell lines, including nasopharyngeal carcinoma, oral hairy leukoplakia, posttransplant lymphoma, post-transplant without pathology mononucleosis, Burkitt's lymphoma, parotid tumor, and normal from distinct geographical regions. The amino- and carboxyl-terminal sequences and, in some cases, the full-length sequences of latent membrane protein 1 were determined. Characteristic sequence patterns distinguished strains, with the carboxyl-terminal sequence being the most informative in distinguishing among the strains. Phylogenetic relationships between strains were determined, as were signature amino acid changes that discriminate between them. A correlation between strain and disease or strain and geographic location was not detected. The sequence variation and signature sequences identified at least seven distinct strains, as well as hybrid strains that apparently result from recombination. (C) 1999 Academic Press.